Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Kintz

Showing results (21-30 of 210) with videos related to

Pageof 21
Sort By:
Journal of Analytical Toxicology|November 5, 2020
What Are the Prerequisites to Account for "No Fault" in Doping Control after an Adverse Analytical Finding Possibly due to Drug Contamination? Perspective from a Hair Testing AnalystPascal Kintz
Current Pharmaceutical Design|October 4, 2017
Hair Analysis in Forensic Toxicology: An Updated Review with a Special Focus on PitfallsPascal Kintz
Clinical Chemistry and Laboratory Medicine|June 3, 2025
No fault or negligence after an adverse analytical finding due to a contaminated supplement: mission impossible. Two examples involving trimetazidinePascal Kintz
Clinical Biochemistry|December 21, 2002
A new series of 13 buprenorphine-related deathsPascal Kintz
Forensic Science International|January 12, 2010
Forensic Science International. EditorialPascal Kintz
Forensic Science International|January 12, 2010
Consensus of the Society of Hair Testing on hair testing for chronic excessive alcohol consumption 2009Pascal Kintz
Forensic Science International|December 6, 2014
2014 consensus for the use of alcohol markers in hair for assessment of both abstinence and chronic excessive alcohol consumptionPascal Kintz
Journal of Pharmaceutical and Biomedical Analysis|October 29, 2021
The forensic response after an adverse analytical finding (doping) involving a selective androgen receptor modulator (SARM) in human athletePascal Kintz
Drug Testing and Analysis|September 7, 2010
Guidelines for European workplace drug and alcohol testing in hairRonald Agius, Pascal Kintz,
Drug Testing and Analysis|September 17, 2024
Interest of Hair Tests to Discriminate a Tail End of a Voluntary Doping Regimen From the Use of a Contaminated Medicine in Case of Challenging an Antidoping Rule Violation. VI. Case Example With TrimetazidinePascal Kintz, Laurie Gheddar
Pageof 21

Showing results (21-30 of 210) with videos related to

Sort By:
Pageof 21
Journal of Analytical Toxicology|November 5, 2020
What Are the Prerequisites to Account for "No Fault" in Doping Control after an Adverse Analytical Finding Possibly due to Drug Contamination? Perspective from a Hair Testing AnalystPascal Kintz
Current Pharmaceutical Design|October 4, 2017
Hair Analysis in Forensic Toxicology: An Updated Review with a Special Focus on PitfallsPascal Kintz
Clinical Chemistry and Laboratory Medicine|June 3, 2025
No fault or negligence after an adverse analytical finding due to a contaminated supplement: mission impossible. Two examples involving trimetazidinePascal Kintz
Clinical Biochemistry|December 21, 2002
A new series of 13 buprenorphine-related deathsPascal Kintz
Forensic Science International|January 12, 2010
Forensic Science International. EditorialPascal Kintz
Forensic Science International|January 12, 2010
Consensus of the Society of Hair Testing on hair testing for chronic excessive alcohol consumption 2009Pascal Kintz
Forensic Science International|December 6, 2014
2014 consensus for the use of alcohol markers in hair for assessment of both abstinence and chronic excessive alcohol consumptionPascal Kintz
Journal of Pharmaceutical and Biomedical Analysis|October 29, 2021
The forensic response after an adverse analytical finding (doping) involving a selective androgen receptor modulator (SARM) in human athletePascal Kintz
Drug Testing and Analysis|September 7, 2010
Guidelines for European workplace drug and alcohol testing in hairRonald Agius, Pascal Kintz,
Drug Testing and Analysis|September 17, 2024
Interest of Hair Tests to Discriminate a Tail End of a Voluntary Doping Regimen From the Use of a Contaminated Medicine in Case of Challenging an Antidoping Rule Violation. VI. Case Example With TrimetazidinePascal Kintz, Laurie Gheddar
Pageof 21